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Abstract: Di-(2-ethylhexyl) phthalate (DEHP) is widely used as a plasticizer in various products such as PVC-derived plastics, toys,
packaging materials, cosmetics, and pharmaceuticals. This study aimed to investigate the effect of DEHP on spontaneous contractions
of the feline uterus in vitro. Tubal 1-cm uterine samples prepared from 10, 9, and 12 uteri obtained from adult cats in estrus (n = 5),
diestrus (n = 5), and interestrus (n = 5), respectively, after ovariohysterectomy were suspended in an isolated organ bath in aerated Krebs
solution at 39 ± 1 °C, and an initial 1 g tension was given. After 1 h equilibration of tissues, the spontaneous contractions were recorded
for 10 min as control. The effects of solvent and DEHP (0.001–100 µM) on contractions were then evaluated in terms of frequency and
mean amplitude parameters. It was observed that DEHP had no effect on uterine contractions of cats in interestrus. However, DEHP
significantly increased the mean amplitude of uterine contractions during the estrus and diestrus periods at concentrations of 1 µM and
10 µM, respectively, depending on the dose (P < 0.05). Decreases in the frequency of the contractions in the estrus and diestrus periods
were not statistically significant (P > 0.05). This study, carried out for the first time in cats, showed that DEHP has a stimulatory effect
on uterine contractions. We concluded that disruption of the uterine contractions, which are essential for physiological reproductive
processes such as regular estrous cycles, sperm and zygote transport, implantation and continuation of pregnancy, by DEHP exposure
may cause many reproductive problems.
Key words: DEHP, feline, uterus, spontaneous contraction, reproduction

1. Introduction
Phthalate esters are synthetic organic chemicals derived
from phthalic acid which are used as a plasticizer to
make rigid plastics such as polyvinyl chloride which have
elasticity, transparency, pliability, and durability [1]. Di(2ethylhexyl) phthalate (DEHP) is one of the most widely
utilized among the number of phthalates of which 18
billion tons per year are produced throughout the world,
and which are found in approximately 40% of plastics [2].
Bottles, containers, food packaging materials, medical
devices, cosmetics, and building materials are commonly
used products which contains DEHP in their structure [3].
Since these chemicals are bound to plastics noncovalently,
they are leached easily and rapidly out of the products into
the environment. Contaminated air, soil, food, and water
are the main potential exposure sources for human and
animals [2,3]. Pets are also exposed to phthalates through
training devices, toys, and veterinary medicine equipment
[4,5]. Their exposure to these chemicals is greater than
humans’ because they are closer to contaminated sources.

According to the report of a study conducted with cats
and dogs, the average levels of many chemicals in blood
and urine were higher in pets than in humans [5]. Serum
DEHP concentrations of cats living in the Paris area were
reported to be 32.9 ng/L [6], and urinary levels of phthalic
acids were measured with a median of 630 ng/mL in pets
[7]. Additionally, pets develop and age faster than humans,
and their health problems develop more rapidly [5].
As it is a widespread environmental toxic chemical,
DEHP leads to many adverse effects on metabolic [8],
nervous [9], cardiovascular [10], and reproductive systems
as well [11] in living organisms. Mariana et al. [10] have
demonstrated that DEHP at higher doses can inhibit
L-type calcium (Ca2+) channels and cause relaxation on
potassium chloride (KCl)-induced contractions of the rat
aorta. Similarly, the number of dilated blood vessels in the
uterine wall were enhanced in DEHP-exposed mice [12].
On the other hand, DEHP increased the blood pressure of
about 20% of mice offspring following maternal exposure
[13], and increased contraction-related gene expression
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in rat cardiomyocytes [14]. In an epidemiological study,
positive correlations between phthalate levels (including
DEHP) in cord blood and preterm delivery in women who
had no history of occupational exposure to phthalates
were shown [15]. DEHP also leads to disruption in
endometrial receptivity and a reduction in the number
of implanted embryos in mice [16]. The implantation of
embryos and endometrial receptivity are critical aspects
of pregnancy which are under the control of reproductive
steroids estrogen (E2) and progesterone (P4) [17]. These
steroids also regulate the contractions of the uterus, which
change during the estrous cycle and support fertilization
and gestation [18]. However, previous studies have shown
that DEHP can interfere with steroidogenesis and/or
receptor functions via its endocrine-disrupting effect
[19–22]. The uterus has steroid receptors and is one of
the main target organs for ovarian hormones. In vivo
exposure of rats [23] or mice [12] to DEHP for 30 days
resulted in alterations in uterus diameter, the number of
uterine glands, serum steroid concentrations, and steroid
receptors in the uterus. Lactational exposure to DEHP
entails a reduction in the thickness of the myometrial
layer of the rat uterus [24]; DEHP has also been suggested
to induce uterine leiomyoma [25] or breast cancer [26]
in women by increasing cell proliferation. These adverse
effects may originate from the estrogenic effect of DEHP
[27]. Although the reprotoxic effects of DEHP have already
been shown in many studies in human and rodents, we
still have lack of knowledge on the effects of DEHP on
uterine contractions, especially in cats. Therefore, in this
study reported for the first time, we aimed to investigate
how DEHP affects in vitro spontaneous contractions of the
feline uterus at various stages of the estrous cycle.
2. Materials and methods
2.1. Animals
Uterine tissues used in this study were collected from
15 healthy, mixed breed, 1–2-year-old queens following
ovariohysterectomy in the Small Animal Clinics of
Kirikkale University Faculty of Veterinary Medicine.
The queens did not have any reproductive diseases, had
not been medicated (in terms of contraceptives), nor had
previous pregnancies. All procedures of the experiments
were conducted with approval of the Local Ethical
Committee of Kırıkkale University, Turkey (2019/3-26).
2.2. Determination of the estrous phase
The queens (n = 15) from which we obtained uterine tissues
were classified into 3 groups according to their phase
of the estrous cycle: estrus (n = 5), diestrus (n = 5), and
interestrus (n = 5). Classification of estrous cycle phases
was performed according to behavioral observations,
follicle/corpus luteum existence in ovaries, and serum
estradiol and progesterone levels. It was assumed that cats
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showing heat signs such as lordosis, rolling, and vocalizing
as well as having follicles on their ovaries were in estrus.
Cats without heat signs and having corpus luteum on their
ovaries were assumed to be in diestrus [28,29]. Serum E2
and P4 concentrations were measured from blood samples
taken from the vena cephalica antebrachia of queens prior
to ovariohysterectomy. Once the blood clotted and was
centrifugated at 1000 g for 10 min at 4 °C, the collected
sera were frozen at –20 °C until hormone analysis was
completed. The concentrations of E2 and P4 of the sera were
assessed by electrochemiluminescence immunoassay kits
(Roche Diagnostic, Indianapolis, IN, USA) with the Roche
Cobas E601 analyzer according to the kit manufacturer’s
recommendations. In addition to estrus behavioral signs
and morphological examinations of the ovaries, with the
assessment of steroid levels, uterine tissues taken from cats
with E2 levels higher than 20 pg/mL were classified as in
estrus. The uterine tissues taken from cats with P4 levels
higher than 1.5 ng/mL were classified as in diestrus. The
uterine tissues taken from cats with E2 and P4 levels lower
than 20 pg/mL and 1.5 ng/mL, respectively, were classified
as in interestrus. The proestrus phase was omitted because
it is difficult to distinguish from estrus [30].
2.3. Isolated feline uterine samples
Once collected, the uterine tissues were placed in Krebs
solution at pH 7.4 containing the following: NaCl 118
mM, KCl 4.69 mM, MgSO4 0.6 mM, NaHCO3 25 mM,
CaCl2 2.5 mM, and glucose 11.1 mM (Merck KGaA,
Darmstadt, Germany) dissolved in 1 L deionized water,
and transported to the laboratory within 2–5 min at 20–22
°C. All procedures in the experiments were performed
according to the protocols of our previous study [31].
Briefly, the harvested uterine tissues were freed from
blood vessels and the surrounding adipose tissues, and
10–12-mm tubal segments were separated out from the
ovarian side of each horn in Petri dishes containing Krebs
solution. The uterine samples were mounted vertically
in a tissue bath (IOBS 99 Isolated Tissue Bath Stand Set;
Commat, Ankara, Turkey), in which one end (ovarian
side) was attached to force transducers and the other end
was attached to a glass holder prefilled with 10 mL Krebs
solution bubbled with an atmosphere of 95% O2 and 5%
CO2 at 39 ± 1 °C.
2.4. Recording and treatments
An initial tension of 1 g was given to tissues and the
samples were allowed to equilibrate for 1 h by rinsing
with fresh Krebs every 15 min before taking the control
recordings. During the experiments, the spontaneous
uterine contractions were measured with a forcedisplacement transducer (FDT 05 MAY, Commat) and
recorded using an MP35 Biopac system (Biopac Systems,
Goleta, CA, USA). Tissue samples which were not seen to
have optimal spontaneous contractions until the end of
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equilibration were excluded from the study. Therefore, the
contractions were monitored from 10, 9, and 12 uterine
preparations of feline in estrus, diestrus, and interestrus,
respectively.
After the tissue stabilization period, spontaneous
contractions were recorded for 10 min as control values
while the tissues were continually perfused with Krebs
solution. Each uterine sample served as its own control.
Subsequently, uterine samples were exposed to the
vehicle (0.1% dimethyl sulfoxide: DMSO) and different
cumulative concentrations of DEHP, and contraction
responses were recorded for 10 min to compare with the
control value. The DEHP (Sigma-Aldrich Corp., St. Louis,
MO, USA) was dissolved in DMSO and diluted in Krebs
solution. The tissues were exposed to a concentration of
DEHP for 10 min, and then the next higher concentration
of DEHP was added to the bath. The final doses of DEHP
in the bath were 0.001, 0.01, 0.1, 1, 10, and 100 µM. The
doses of DEHP used in this study were based on previous
in vitro toxicological studies [10,11] and our preliminary
experiments with feline uterine tissue.
2.5. Data and statistical analysis
The frequency (number of contractions) and the mean
amplitude of uterine contractions were calculated manually
from 10-min recordings of the control and all treatment
groups. These parameters obtained from recordings are
presented as percentages of control contractions, i.e. the
control was 100% and the other groups were determined
by comparing the results to the control. All the data were
expressed as the mean ± standard error mean (SEM), and
statistically analyzed with GraphPad Prism 6.0 (GraphPad
Software, San Diego, CA, USA) by comparing the control
with each group. The analyses were performed by using a
one-way ANOVA followed by Dunnett’s test for post-hoc
comparison. The value considered statistically significant
was P < 0.05.
3. Results
3.1. Serum steroid hormone levels
The E2 and P4 concentrations analyzed from the sera are
shown in Table 1. These values supported the classification

of stages in the estrous cycle performed according to
clinical observation and macroscopic examination of the
ovaries of cats. Therefore, the serum E2 and P4 levels were
as follows: >20 pg/mL and <1.5 ng/mL for cats in estrus;
<20 pg/mL and >1.5 ng/mL for cats in diestrus; <20 pg/mL
and <1.5 ng/mL for cats in interestrus, respectively.
3.2. Spontaneous uterine contractions
The frequencies and mean amplitudes of spontaneous
contractions measured from uterine segments of felines
in estrus, diestrus, and interestrus during the 10-min
control period are given in Table 2. The findings obtained
from control groups were considered to be 100%, and the
percentages for the other treatment groups were calculated
by comparing the results to the control. The effects of the
vehicle DMSO on the frequencies and mean amplitudes
of spontaneous contractions were not significant compare
to the control in any phases of the estrous cycle (P > 0.05).
However, different concentrations of DEHP (0.001–
100 μM) treatment of the uterine samples significantly
affected the amplitudes of spontaneous contractions dosedependently and based on the phases of the estrous cycle
(P < 0.05).
3.3. Effects of DEHP on in vitro spontaneous feline
uterine contractions in estrus
The representative tracings in Figure 1A demonstrate
the details for the responses of the tissues to the control
conditions and treatment with different doses of DEHP
(0.001–100 μM) on feline uterine contractions in the estrus
phase of the reproductive cycle. Although administration
of different doses of DEHP to the uterine samples caused
a reduction in the frequency of spontaneous isometric
contractions (Figure 1B), the measured data were not
statistically different from those of the control (P > 0.05).
As shown in Figure 1B, all of the concentrations of
DEHP used in this study increased the mean amplitude
of contractions dose-dependently. When the stimulatory
effect of DEHP on the contractions’ amplitude was
compared to the control, effects of DEHP at the doses of
0.001–0.1 μM were not statistically remarkable. However, 1
μM DEHP significantly enhanced the force of contractions
(P < 0.05). The next higher 2 concentrations of DEHP (10

Table 1. The serum estradiol and progesterone concentrations of cats in different
phases of estrous cycle.

Phases of estrous cycle

Serum steroid concentrations
Estradiol (pg/mL)

Progesterone (ng/mL)

Estrus (n = 5)

29.46 ± 5.38

0.63 ± 0.08

Diestrus (n = 5)

10.18 ± 2.47

22.22 ± 4.04

Interestrus (n = 5)

11.92 ± 2.28

0.92 ± 0.26
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Table 2. The frequencies and mean amplitudes of spontaneous
contractions of feline uterine segments in different phases of
estrous cycle.

Phases of estrous cycle

Uterine contractions of 10-min
Mean amplitude (g)

Frequency

Estrus (n = 10)

3.1 ± 0.5

14.8 ± 1.2

Diestrus (n = 9)

3.9 ± 0.7

9.04 ± 1.0

Interestrus (n = 12)

3.8 ± 0.6

12.4 ± 0.8

and 100 μM) also dramatically increased the contractile
activity of uterine in terms of the mean amplitude
compared to the control (P < 0.01).
3.4. Effects of DEHP on in vitro spontaneous feline
uterine contractions in diestrus
The details for the responses of the feline uterine
contractions with diestrus in the control and different
DEHP (0.001–100 μM) concentrations for the treated
groups are demonstrated in the representative tracings in
Figure 2A. The calculated frequency values of the DEHP

treatment groups were lower than those of the control
(Figure 2B). Nevertheless, this difference did not have
significance according to statistical analyses (P > 0.05).
It can be seen in Figure 2B that the application of DEHP
at doses of 0.001–1 μM enhanced the mean peak amplitude
of contractions but was not significant (P > 0.05), while
the responses of the spontaneous contractions in terms of
amplitude were significantly increased by the highest 2
DEHP concentrations (10 and 100 μM) compared to the
control (P < 0.05).
3.5. Effects of DEHP on in vitro spontaneous feline uterine contractions in interestrus
In vitro exposure of uterine samples to DEHP
concentrations did not alter either the mean amplitude
or the frequency of contractions (Figures 3A and 3B).
Although there was a slight increase in the forces of
contractions at doses of DEHP of 0.01 μM and above, it
was not statistically significant (P > 0.05).
4. Discussion
During the last few decades, adverse effects of endocrine
disrupting chemicals (EDCs) on physiological systems of
living organisms have caused increasing public concern.

Figure 1. Effects of vehicle (DMSO) and cumulative concentrations of DEHP (0.001–100 μM) on the frequency and mean amplitude
of feline uterine contractions in estrus phases. The upper panel (A) demonstrates the representative tracings of responses of uterine
contractions to control condition and DEHP exposure for 10 min. the lower panel (B) presents the graph of data expressed as the mean
±SEM (n = 10). The responses in DEHP-treated groups were significantly different from control (*: P < 0.05 and **: P < 0.01). Ctrl:
Control, DMSO: Demthyl sulphoxide, DEHP: Diethylhexyl phthalate.

922

KABAKÇI et al. / Turk J Vet Anim Sci

Figure 2. Effects of vehicle (DMSO) and cumulative concentrations of DEHP (0.001–100 μM) on the frequency and mean amplitude
of feline uterine contractions in diestrus phases. The upper panel (A) demonstrates the representative tracings of responses of uterine
contractions to control condition and DEHP exposure for 10 min. the lower panel (B) presents the graph of data expressed as the mean
±SEM (n = 9). The responses in DEHP-treated groups were significantly different from control (*: P < 0.05). Ctrl: Control, DMSO:
Demthyl sulphoxide, DEHP: Diethylhexyl phthalate.

Researchers are particularly interested in their detrimental
effects on reproductive systems [16]. DEHP is one of the
most widely used phthalates among EDCs. Although the
reprotoxic effects of DEHP have been reported in earlier
studies [11,20,32,33], little attention has been given to its
effects on the contractile activity of the uterus. In the present
study, we investigated how DEHP, in a range of 0.001–100
μM concentrations, affects feline uterine contractions in
various reproductive phases. Our observations first showed
that DEHP stimulated spontaneous uterine activity of
female cats depending on the estrous cycle. In a few recent
reports, phthalates including DEHP have been detected
in urine [7] and blood [6] of cats, and it is suggested that
pets have been exposed to these chemicals via pet toys,
training devices, and veterinary medicine equipment
[4,5], as well as different environmental sources. EDCs do
not have monotonic dose-response curves since they have
more potent effects at low/high doses than high/low doses
[34]. Hence, studying a wide range of concentrations gives
more accurate and reliable results than a narrow range of
concentrations [11,34]. Therefore, we chose the doses of
0.001–100 μM for DEHP, as in previous studies [10,35,36].
In the present study, DEHP exhibited different effects
on feline uterine contractions which were grouped in terms

of estrous cycle according to behavioral observations,
follicle/corpus luteum existence in ovaries, and serum E2
and P4 levels as compatible with earlier studies [28–30].
Our findings showed that DEHP significantly (P < 0.05)
increased the mean amplitude of uterine contractions at
higher doses from 1 μM to 10 μM in estrus and diestrus,
respectively. However, the force of contractions was not
altered with exposure to DEHP in the interestrus phase.
Serum E2 levels are high during the estrus phase of the
reproductive cycle and E2 upregulates oxytocin receptors
in the uterus, resulting in increased contractions [37]. In
an in vivo study, it has been shown that uterine responses
of cats to oxytocics were elevated with a 1-mg estrogen
injection [38]. Wang et al. [39] have reported that 0.1–10
ng/mL DEHP stimulated secretions of prostaglandin F2α
and oxytocin in bovine ovarian and endometrial cells,
but inhibited prostaglandin E2. The authors suggested
that these changes may increase the contractile activity
of myometrium. Additionally, the estrogenic activity
of DEHP has previously been described; it induced the
proliferation of breast cancer cells in vitro even at low doses
(10 nM) [26,27]. In vivo exposure of rats to DEHP caused
uterine cell proliferation [23], and gradually decreased the
embryo implantation number in mice depending on the
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Figure 3. Effects of vehicle (DMSO) and cumulative concentrations of DEHP (0.001–100 μM) on the frequency and mean amplitude of
feline uterine contractions in interestrus phases. The upper panel (A) demonstrates the representative tracings of responses of uterine
contractions to control condition and DEHP exposure for 10 min. The lower panel (B) presents the graph of data expressed as the mean
±SEM (n = 12). The responses in DEHP-treated groups were not significantly different from control (P > 0.05). Ctrl: Control, DMSO:
Demthyl sulphoxide, DEHP: Diethylhexyl phthalate.

dose [16]. Therefore, the stimulatory effect of DEHP on
the force of spontaneous uterine contractions may have
resulted from its estrogenic activity. The findings that the
amplitude of contractions did not differ from the control
in the interestrus phase support our suggestion. In the
reproductive season, unovulated felines go through estrus
and interestrus phases in turn in which the E2 level is
higher and lower, respectively [29]. Thus, estrogen-related
effects of DEHP may disappear in this phase of the estrous
cycle. On the other hand, in vitro DEHP (0.001–100 μM)
exposition of the rat aorta led to relaxation of KCl-induced
contractions [10]. Azevedo et al. [40] also demonstrated
that similar DEHP concentrations reduced the histamine
and KCl-induced contractions of the human umbilical
artery,
while
5-hydroxytryptamine(5-HT)-induced
contractions increased. Mariana et al. [10] have suggested
that the vasorelaxant effect of DEHP on rat aorta may
result in inhibiting L-type Ca2+ channels, but Azevedo et
al. [40] did not agree with them, due to different results
with KCl- and 5-HT-induced contractions of the human
umbilical artery. Posnack et al. [14] demonstrated that
DEHP treatment increased the expression of some genes
associated with Ca2+ handling, including voltage-gated
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L-type Ca2+ channels. In addition, we also found that
DEHP increased uterine contractions, while in a previous
study, DEHP had no effect on contractions of the gastric
muscle [41]. Dissimilar effects of DEHP on smooth
muscles belonging to different tissues denote that further
studies are required.
There are 2 mechanisms that stimulate uterine
contractions: electrochemical and pharmacomechanical
coupling. In the first, the action potential that initiates
contractions is formed by the electrochemical mechanism
which changes Ca2+ permeability by stimulating the
voltage-gated Ca2+ channels [42]. However, as shown
in the results of previous studies [10,40] the effects of
DEHP on the voltage-gated L-type Ca2+ channels are
still uncertain. In the pharmacomechanical coupling
mechanism, secondary messengers are activated by the
binding of membrane receptors and agonists, which leads
to the increased influx of Ca2+ ions into the cell [42].
Liu and Lin [43] have reported that phthalates including
DEHP may modulate the activity of membrane ion
channels, and have also suggested that among receptorgated Ca2+ channels, nicotinic acetylcholine receptors are
more sensitive to phthalates than voltage-gated channels.
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Thus, DEHP may enhance the amplitude of contractions
by altering the activity of ligand-gated channels.
Progesterone released in high levels during diestrus
physiologically reduces uterine activity, calming
the uterus, while estrogens induce contractility and
excitability [44]. Spontaneous activity of the uterus must
be kept under control by ovarian steroids for the success
and maintenance of many reproductive processes [45].
Although serum E2 level is lower in the diestrus phase,
DEHP also stimulated the mean amplitude of contractions
in that phase. It was shown in earlier studies that DEHP
intervened in steroidogenesis in ovarian cells by inhibiting
synthesis or secretion of reproductive steroids including
progesterone [19,20,46]. Therefore, the stimulatory effects
of DEHP on the force of uterine contractions in diestrus
may be related to its inhibitory effects on P4 secretion,
which suppress the gene expression of contractionassociated proteins in order to relax the myometrium [47].
However, more comprehensive studies will be needed to
explain the underlying mechanisms.
According to our observations, treatment of feline
uterine samples with various DEHP concentrations
(0.001–100 μM) did not alter the frequency of spontaneous
contractions in any phases of the estrous cycle, unlike
the mean amplitude. Similarly, different effects were
observed on the frequency and amplitude of contractions
with the exposure of rat or cat uterus to bisphenol A,
another commonly used plasticizer/EDC, which has been
associated with the control of frequency and amplitude
by different mechanisms [31,48]. Although myometrial

activity is stimulated by a single action potential, more
coordinated depolarizations are required for forceful
and continual contractions which could be affected by
the number of action potentials [44,49]. Therefore, the
amplitude of contractions may be more sensitive to DEHP
than are frequencies.
In conclusion, many reproductive processes such
as transport of sperm and oocytes, fertilization and
embryo implantation, and continuation of pregnancy
are related to suitable uterine contractions. Our results
indicated that DEHP induced feline uterine contractions
in different degrees depending on the estrous cycle
periods. Because DEHP may have modulatory effects
on membrane receptors and channels, especially Ca2+
channels [43], it may have stimulated contractions by
increasing intracellular Ca2+ concentrations or estrogenic
activity. The lack of studies on the effects of DEHP on
smooth muscle, including myometrium, has caused some
difficulties for comparing our results with the findings of
other researchers. Nevertheless, we could conclude that
DEHP may cause reproductive problems in felines by
disrupting the balance of uterine activity.
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